Iniesta MD - Search Results

1

MRE11 deficiency increases sensitivity to poly(ADP-ribose) polymerase inhibition in microsatellite unstable colorectal cancers.

Vilar E, Bartnik CM, Stenzel SL, Raskin L, Ahn J, Moreno V, Mukherjee B, Iniesta MD, Morgan MA, Rennert G, Gruber SB. Vilar E, et al. Among authors: iniesta md. Cancer Res. 2011 Apr 1;71(7):2632-42. doi: 10.1158/0008-5472.CAN-10-1120. Epub 2011 Feb 7. Cancer Res. 2011. PMID: 21300766 Free PMC article.

2

MLH1 promoter hypermethylation in the analytical algorithm of Lynch syndrome: a cost-effectiveness study.

Gausachs M, Mur P, Corral J, Pineda M, González S, Benito L, Menéndez M, Espinàs JA, Brunet J, Iniesta MD, Gruber SB, Lázaro C, Blanco I, Capellá G. Gausachs M, et al. Among authors: iniesta md. Eur J Hum Genet. 2012 Jul;20(7):762-8. doi: 10.1038/ejhg.2011.277. Epub 2012 Jan 25. Eur J Hum Genet. 2012. PMID: 22274583 Free PMC article.

3

MLH1 methylation screening is effective in identifying epimutation carriers.

Pineda M, Mur P, Iniesta MD, Borràs E, Campos O, Vargas G, Iglesias S, Fernández A, Gruber SB, Lázaro C, Brunet J, Navarro M, Blanco I, Capellá G. Pineda M, et al. Among authors: iniesta md. Eur J Hum Genet. 2012 Dec;20(12):1256-64. doi: 10.1038/ejhg.2012.136. Epub 2012 Jul 4. Eur J Hum Genet. 2012. PMID: 22763379 Free PMC article.

4

One-hit effects and cancer.

Iniesta MD, Chien J, Wicha M, Merajver SD. Iniesta MD, et al. Cancer Prev Res (Phila). 2010 Jan;3(1):12-5. doi: 10.1158/1940-6207.CAPR-09-0249. Cancer Prev Res (Phila). 2010. PMID: 20051368 Review.

5

Androgen receptor polyglutamine tract length in Egyptian male breast cancer patients.

Gilbert SF, Soliman AS, Iniesta M, Eissa M, Hablas A, Seifeldin IA, Strahley A, Banerjee M, Merajver SD. Gilbert SF, et al. Breast Cancer Res Treat. 2011 Sep;129(2):575-81. doi: 10.1007/s10549-011-1510-6. Epub 2011 Apr 20. Breast Cancer Res Treat. 2011. PMID: 21505847 Free PMC article.

6

Absence of CHEK2*1100delC mutation in families with hereditary breast cancer in North America.

Iniesta MD, Gorin MA, Chien LC, Thomas SM, Milliron KJ, Douglas JA, Merajver SD. Iniesta MD, et al. Cancer Genet Cytogenet. 2010 Oct 15;202(2):136-40. doi: 10.1016/j.cancergencyto.2010.07.124. Cancer Genet Cytogenet. 2010. PMID: 20875877

7

Development of PARP inhibitors in oncology.

Rodon J, Iniesta MD, Papadopoulos K. Rodon J, et al. Among authors: iniesta md. Expert Opin Investig Drugs. 2009 Jan;18(1):31-43. doi: 10.1517/13543780802525324. Expert Opin Investig Drugs. 2009. PMID: 19053880 Review.

8

Inflammatory breast cancer: what are the treatment options?

Iniesta MD, Mooney CJ, Merajver SD. Iniesta MD, et al. Expert Opin Pharmacother. 2009 Dec;10(18):2987-97. doi: 10.1517/14656560903401638. Expert Opin Pharmacother. 2009. PMID: 19954272 Review.

9

CHEK2 screening: do not think so globally yet.

Iniesta MD, Merajver SD. Iniesta MD, et al. J Clin Oncol. 2008 Jun 20;26(18):3092; author reply 3093-4. doi: 10.1200/JCO.2008.16.9151. J Clin Oncol. 2008. PMID: 18565899 No abstract available.

10

Enhanced recovery after surgery (ERAS®) in gynecologic oncology - Practical considerations for program development.

Nelson G, Dowdy SC, Lasala J, Mena G, Bakkum-Gamez J, Meyer LA, Iniesta MD, Ramirez PT. Nelson G, et al. Among authors: iniesta md. Gynecol Oncol. 2017 Dec;147(3):617-620. doi: 10.1016/j.ygyno.2017.09.023. Epub 2017 Sep 23. Gynecol Oncol. 2017. PMID: 28947172 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

44 results

Search Page